全文获取类型
收费全文 | 186511篇 |
免费 | 12223篇 |
国内免费 | 2187篇 |
专业分类
耳鼻咽喉 | 2308篇 |
儿科学 | 7380篇 |
妇产科学 | 3091篇 |
基础医学 | 13938篇 |
口腔科学 | 5096篇 |
临床医学 | 23141篇 |
内科学 | 33287篇 |
皮肤病学 | 3747篇 |
神经病学 | 16651篇 |
特种医学 | 27779篇 |
外国民族医学 | 18篇 |
外科学 | 29537篇 |
综合类 | 9594篇 |
现状与发展 | 1篇 |
预防医学 | 7292篇 |
眼科学 | 3447篇 |
药学 | 7051篇 |
62篇 | |
中国医学 | 1060篇 |
肿瘤学 | 6441篇 |
出版年
2023年 | 4718篇 |
2022年 | 6679篇 |
2021年 | 8946篇 |
2020年 | 7361篇 |
2019年 | 14396篇 |
2018年 | 11554篇 |
2017年 | 7479篇 |
2016年 | 4748篇 |
2015年 | 5224篇 |
2014年 | 8037篇 |
2013年 | 6094篇 |
2012年 | 5472篇 |
2011年 | 9237篇 |
2010年 | 5367篇 |
2009年 | 5914篇 |
2008年 | 5937篇 |
2007年 | 5198篇 |
2006年 | 4514篇 |
2005年 | 4561篇 |
2004年 | 4138篇 |
2003年 | 3034篇 |
2002年 | 3170篇 |
2001年 | 3435篇 |
2000年 | 4115篇 |
1999年 | 4223篇 |
1998年 | 4003篇 |
1997年 | 2968篇 |
1996年 | 2152篇 |
1995年 | 1631篇 |
1994年 | 1527篇 |
1993年 | 1113篇 |
1992年 | 1071篇 |
1991年 | 849篇 |
1990年 | 819篇 |
1989年 | 571篇 |
1988年 | 605篇 |
1987年 | 418篇 |
1985年 | 2789篇 |
1984年 | 4074篇 |
1983年 | 2903篇 |
1982年 | 2850篇 |
1981年 | 2687篇 |
1980年 | 2376篇 |
1979年 | 2196篇 |
1978年 | 1808篇 |
1977年 | 1566篇 |
1976年 | 1693篇 |
1975年 | 1437篇 |
1974年 | 1266篇 |
1973年 | 1201篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
41.
42.
43.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):150-154.e2
Thoracic endovascular aortic repair (TEVAR) for aneurysmal chronic dissection is often complicated by retrograde filling of the false lumen and dissected distal landing zone. A “cheese wire”-style fenestration of the dissection intimal flap can create a landing zone facilitating TEVAR. This technique successfully aided TEVAR in 3 patients with an average age of 57.3 years. Complications included type III endoleak requiring relining and renal artery occlusion requiring stent placement. Average duration of clinical follow-up was 19 ± 4 months. Imaging follow-up was 8 ± 10 months. All patients have survived for more than 1 year without aneurysm enlargement. 相似文献
44.
45.
46.
《Journal of vascular and interventional radiology : JVIR》2020,31(4):630-634
PurposeTo retrospectively evaluate the safety and effectiveness of the Covera stent graft (SG) for the treatment of dysfunctional or thrombosed arteriovenous grafts (AVGs).Materials and MethodsWithin 29 months (February 2016–August 2018), 79 patients underwent Covera SG placement in the authors’ department for the treatment of dysfunctional AVGs. Data were available for 64 patients who underwent 64 procedures, using 64 devices. Minimum follow-up was 6 months, unless reintervention occurred. Mean follow-up was 277 days (6–923 days). Treatment characteristics were 51 cases with venous-graft anastomosis (VGA) stenosis (79.7%), 13 cases of puncture zone stenosis (20.3%), 14 cases of in SG stenosis (21.9%), 8 cases of pseudoaneurysm treatment (12.5%) (1 treatment area might have had more than 1 characteristic). Thirty-six patients presented with thrombosis (56.2%), and 31 of 64 case were de novo treatment areas (48.4%). Primary outcome measurements were technical success and post-intervention primary patency (PIPP) at 6 months, whereas secondary outcome measurements included factors influencing primary outcome.ResultsTechnical success was 100%. Median PIPP was 336 days, and 73.6% of treatment areas were patent at 6 months. There were no significant differences in terms of PIPP when de novo treatment areas were compared with restenotic areas (519 vs. 320 days, respectively; P = .1); patients who presented with versus those who presented without thrombosis (320 vs. 583 days, respectively; P = .07); puncture zone stenosis or elsewhere (329 vs. 686 days, respectively; P = .52); and VGA stenosis or elsewhere (336 vs. 335 days, respectively; P = .9).ConclusionsUse of the Covera SG for AVG treatment was safe and effective in every type of treatment area presented in this retrospective analysis. 相似文献
47.
48.
49.
50.